N.V. Texofab Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 4.40 M
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.61 Cr
- Revenue Growth 28.45%
- Profit Growth 40.41%
- Ebitda 172.66%
- Net Worth 5.01%
- Total Assets -10.25%
About N.V. Texofab
N.V. Texofab Private Limited (NTPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 21 March 2014 and has a history of Ten years and ten months. Its registered office is in Surat, Gujarat, India.
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.40 M.
The company currently has active open charges totaling ₹4.61 Cr.
Nikshan Sutariya, Piyush Sutariya, Vimalbhai Pavasiya, and One other member serve as directors at the Company.
Company Details
-
Location
Surat, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U17291GJ2014PTC079256
-
Company No.
079256
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Mar 2014
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at N.V. Texofab?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nikshan Sutariya
|
Director | 21-Mar-2014 | Current |
|
Piyush Sutariya
|
Director | 21-Mar-2014 | Current |
|
Vimalbhai Pavasiya
|
Director | 21-Mar-2014 | Current |
|
Bharatbhai Patel
|
Director | 21-Mar-2014 | Current |
Financial Performance of N.V. Texofab.
N.V. Texofab Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 28.45% increase. The company also saw a substantial improvement in profitability, with a 40.41% increase in profit. The company's net worth moved up by a moderate rise of 5.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of N.V. Texofab?
In 2021, N.V. Texofab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Shreepramukh Solar Energy FoundationVimalbhai Pavasiya is a mutual person
Charges (Loans)
₹46.12 M
₹0
Charges Breakdown by Lending Institutions
- The Surat People'S Co-Op Bank Ltd. : 4.61 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Dec 2014 | The Surat People's Co-Op Bank Ltd. | ₹2.61 Cr | Open |
| 02 Dec 2014 | The Surat People's Co-Op Bank Ltd. | ₹2.00 Cr | Open |
How Many Employees Work at N.V. Texofab?
Unlock and access historical data on people associated with N.V. Texofab, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of N.V. Texofab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped N.V. Texofab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.